BOULDER — Miragen Therapeutics Inc. (Nasdaq: MGEN) has licensed a protein-engineering platform from California-based Xencor Inc. (Nasdaq: XNCR) as part […]
Source: BizWest
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
BOULDER — Cancer-drug developer MiRagen Therapeutics Inc. (Nasdaq: MGEN) posted a multi-million dollar loss in the last quarter but expects…
BROOMFIELD — Flagship Biosciences Inc., a Broomfield-based spatial-biology company, has formed a strategic partnership with Genomenon Inc., based in Ann…
FORT COLLINS — The new owners who want to revitalize midtown Fort Collins’ half-century-old Foothills mall say they envision “a…
BOULDER — Arpeggio Bioscience Inc., a preclinical-stage pharmaceutical company founded by University of Colorado Boulder doctoral program graduates, has raised…
